期刊文献+

人三叶因子3 shRNA表达质粒的构建及有效序列筛选 被引量:1

Construction and screening effective sequence of shRNA targeting human trefoil factor 3
原文传递
导出
摘要 目的:三叶因子3(trefoil factor 3,TFF3)除具有黏膜保护作用外还与恶性肿瘤的形成、生长、转移有关。本研究通过慢病毒表达质粒介导shRNA,瞬时转染自身表达TFF3的甲状腺乳头状癌K1细胞,筛选出了靶向人TFF3的最有效的siRNA序列。方法:分别在人TFF3基因mRNA的132、170、258和537bp处作为潜在靶位点,合成4条siRNA转录模板的发夹结构(shRNA1-4)以及1条阴性对照(shRNAC),体外退火后插入pLVX-shRNA-puro构建重组质粒,酶切鉴定,并测序。瞬时转染K1细胞、Real-time PCR及western-blot等检测TFF3mRNA和蛋白在转染细胞的表达。结果:shRNA 1-2两条发夹结构序列有基因突变,shRNA 3-4对K1细胞TFF3表达有不同程度的抑制效应(P〈0.01)。其中shRNA3(TFF3 258-276)表现出了最高的沉默效率(转染效率76.83%时,mRNA水平的沉默效率达60.67%;蛋白质水平的沉默效率达56.44%,均P〈0.01)。结论:成功构建了pLVX-shRNA-puro-TFF3慢病毒质粒,并筛选出了最有效的序列,为进一步研究TFF3的功能奠定了基础。 Objective:Trefoil factor 3 plays a pivot role in oncogenic transformation, growth and metastatic extension of solid tumours besides mucosal protection. We screened the best siRNA sequence targeting human TFF3 by the transient-transfection of the lentiviral mediated shRNA into thyroid carcinoma K1 cells which secrete TFF3 themselves. Method: Four siRNA transcription template hairpin structure target potential sites in human TFF3 mRNA sequence(132,170,258 and 537 bp, seperately) were selected and synthesized,as well as one negative shR- NA(shRNAC). After annealing in vitro,insert pLVX-shRNA- puro construct recombinant plasmid, then enzyme digestion and sequencing analysis. The lentiviral-shRNAs were transient-transfected into K1 ceils. TFF3 mRNA and protein levels were test by real-time PCR and western blot respectively in K1 cells at 48h post transient-trans- fected. Result:Genetic mutations in two sequences of shRNA1 - 2, so the follow-up study terminated. The TFF3 expression were obviously inhibited in K1 cells at 48 hours post transient-transfected of shRNA3 and shRNA4. TFF3(258--276)showed the highest silencing effieiency(TFF3 mRNA reduced 60.67 % and TFF3 protein reduced 56.44% ,P〈0.01) when the transfection efficiency was 76.83%. Conclusion.. pLVX-shRNA-puro-TFF3 expres- sion plamid were successfully constructed and the highest efficiency sequences were screened. All these laid a foun- dation for further study about the function of TFF3 gene.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2016年第2期130-134,共5页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 2013年度省级重大医学科研课题(No:zd2013052)
关键词 三叶因子3 慢病毒载体 SHRNA 瞬时转染 trefoil factor lentiviral vector short hair RNA transient transfection
  • 相关文献

参考文献10

二级参考文献34

  • 1翟荣林,王国斌,夏泽峰.c-myc靶向小干扰RNA诱导乳腺癌细胞凋亡的作用[J].中华实验外科杂志,2005,22(6):698-700. 被引量:21
  • 2Joachim Lupberger,Eberhard Hildt.Hepatitis B virus-induced oncogenesis[J].World Journal of Gastroenterology,2007,13(1):74-81. 被引量:57
  • 3崔彦芝,罗荣城.乙型肝炎病毒X蛋白与肝癌研究进展[J].癌症进展,2007,5(4):324-328. 被引量:3
  • 4Iiu YP,Haasnoot J, ter Brake O,et al. Inhibition of HIV-I by multiple siRNAs expressed from a sin^e microRNA polycistron [J]. Nucleic Acids Res, 2008, 36 (9): 2811-2824.
  • 5Voinnet 0. Induction and suppression of RNA silencing : insights from viral infections[J]. Nat Rev Genet,2005,6: 206-220.
  • 6Cobum GA, Cullen BA. siRNAs : a newwave of RNA-based therapeutics [J]. J Antimicrob Chemother, 2003 , 51 (4) : 753-756.
  • 7Dykxhoom DM,Lieberman J. fITie silent revolution : RNA interference as basic biology, research tool, and therapeutic [J]. Annu Rev Med, 2005,56: 401-423.
  • 8Whitehead KA,Langer R,Anderson DG. Knocking down barriers: advances in siRNA delivery [J]. Nat Rev Drug Discov, 2009 , 8(2): 129-138.
  • 9Peer D,Shimaoka M. Systemic siKNA delivery to leukocyte-implicated diseases [J]. Cell Cycle, 2009, 8 (6): 853-859.
  • 10Peter F. HIV NEF: the mother of all evil [J]. Immunity, 1998,9: 433437.

共引文献7

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部